ABO-compatible mismatching decreases 5-year actuarial graft survival after renal transplantation. Read more about ABO-compatible mismatching decreases 5-year actuarial graft survival after renal transplantation.
Mixed islet-lymphocyte culture as a model for pancreatic islet immunogenicity and cell-mediated immune injury. Read more about Mixed islet-lymphocyte culture as a model for pancreatic islet immunogenicity and cell-mediated immune injury.
Reperfusion coagulopathy during human liver transplantation. Read more about Reperfusion coagulopathy during human liver transplantation.
Pediatric liver transplantation using combination immunosuppressive therapy. Read more about Pediatric liver transplantation using combination immunosuppressive therapy.
Major histocompatibility complex class I antigens on hepatocytes in human liver grafts. Read more about Major histocompatibility complex class I antigens on hepatocytes in human liver grafts.
Kidney transplantation in diabetic patients. Read more about Kidney transplantation in diabetic patients.
Permanent acceptance of islet allografts in mice is not associated with immunologic tolerance. Read more about Permanent acceptance of islet allografts in mice is not associated with immunologic tolerance.
Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation. Read more about Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation.
Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin. Read more about Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin.
The role of natural killer cells in the allograft response. Read more about The role of natural killer cells in the allograft response.
